These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31479199)

  • 1. The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients.
    Dimopoulos K; Hansen OK; Sjö LD; Saft L; Schjødt IM; Werner Hansen J; Grønbaek K
    Cytometry B Clin Cytom; 2020 May; 98(3):250-258. PubMed ID: 31479199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
    Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
    Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
    Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
    Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance.
    Kwok B; Hall JM; Witte JS; Xu Y; Reddy P; Lin K; Flamholz R; Dabbas B; Yung A; Al-Hafidh J; Balmert E; Vaupel C; El Hader C; McGinniss MJ; Nahas SA; Kines J; Bejar R
    Blood; 2015 Nov; 126(21):2355-61. PubMed ID: 26429975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience.
    Gao L; Hyter S; Zhang D; Kelting S; Woodroof J; Abdallah AO; Yacoub A; McGuirk J; Abdelhakim H; Godwin AK; Cui W
    Int J Lab Hematol; 2022 Aug; 44(4):738-749. PubMed ID: 35352484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.
    Kaastrup K; Gillberg L; Mikkelsen SU; Ørskov AD; Schöllkopf C; Mortensen BK; Porse B; Hansen JW; Grønbæk K
    Clin Epigenetics; 2023 May; 15(1):91. PubMed ID: 37237325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow Cytometric Findings in Clonal Cytopenia of Undetermined Significance.
    Nirmalanantham P; Sakhi R; Beck R; Oduro K; Gadde R; Ryder C; Yoest J; Sadri N; Meyerson HJ
    Am J Clin Pathol; 2022 Feb; 157(2):219-230. PubMed ID: 34542558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications.
    Valent P
    Pathobiology; 2019; 86(1):30-38. PubMed ID: 29860246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICUS/CCUS/CHIP: basics & beyond.
    Jain M; Tripathi A
    Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT).
    O'Neill C; Nwachukwu N; Vergara-Lluri M; Hagiya A; O'Connell CL
    Eur J Haematol; 2024 Apr; 112(4):594-600. PubMed ID: 38088145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
    Jevremovic D; Nanaa A; Geyer SM; Timm M; Azouz H; Hengel C; Reberg A; He R; Viswanatha D; Salama ME; Shi M; Olteanu H; Horna P; Otteson G; Greipp PT; Xie Z; Alkhateeb HB; Hogan W; Litzow M; Patnaik MM; Shah M; Al-Kali A; Nguyen PL
    Am J Clin Pathol; 2022 Oct; 158(4):530-536. PubMed ID: 35938646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
    Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
    Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Flow Cytometry Standardized Using the European LeukemiaNet for Myelodysplastic Syndrome.
    Takeuchi A; Imataki O; Kubo H; Kondo A; Seo K; Uemura M; Yamaoka G; Murao K; Takeuchi A
    Acta Haematol; 2020; 143(2):140-145. PubMed ID: 31330512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features.
    Ferrone CK; McNaughton AJM; Rashedi I; Ring B; Buckstein R; Tsui H; Rauh MJ
    Mod Pathol; 2023 Mar; 36(3):100068. PubMed ID: 36788103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.
    Nann D; Rau A; Mahmutovic L; Steinhilber J; Meca V; Federmann B; Vogel W; Bonzheim I; Quintanilla-Martinez L; Fend F
    Virchows Arch; 2023 Dec; 483(6):835-845. PubMed ID: 37610626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.
    Breinholt MF; Nielsen K; Schejbel L; Fassi DE; Schöllkopf C; Novotny GW; Mortensen BK; Ahmad A; Høgdall E; Nørgaard P
    Int J Lab Hematol; 2022 Jun; 44(3):531-537. PubMed ID: 35142436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
    Valent P; Bain BJ; Bennett JM; Wimazal F; Sperr WR; Mufti G; Horny HP
    Leuk Res; 2012 Jan; 36(1):1-5. PubMed ID: 21920601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
    Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
    Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of Targeted Sequencing Assay for Patients with Suspected Myeloid Malignancies].
    Zhang LJ; Shi YY; Chen Y; Deng Y; Ding YH; Li Z; Chen KK; Ding BH; Wang CL; Yu L; He ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1985-1990. PubMed ID: 33283730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients.
    Schroeder T; Ruf L; Bernhardt A; Hildebrandt B; Aivado M; Aul C; Gattermann N; Haas R; Germing U
    Ann Oncol; 2010 Nov; 21(11):2267-2271. PubMed ID: 20439346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.